The Cys synthase binds to the STAS domain and reduces the activity of the transporter
PMCID: PMC7428472
Both the American Urological Association and the European Association of Urology Guidelines recommend considering a PDE5 inhibitor as the first-line treatment for ED as long as it doesnt interfere with your other medications or cause you to have any severe side effects
Do not shake vigorously, as this promotes GHK-Cu aggregation and TB-500 denaturation
Several GLS inhibitors have been developed, among which CB-839 is currently undergoing clinical trials as a potent, orally bioavailable GLS-selective inhibitor for the treatment of various cancers, including TNBC, NSCLC, and colon cancer (NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600)